Xalia - Xarelto for Long Term and Initial Anticoagulation in VTE

• Research type

  Research Study

• Full title

  Xalia - Xarelto for Long Term and Initial Anticoagulation in Venous Thromboembolism

• IRAS ID

  94981

• Contact name

  Roopen Arya

• Contact email

  roopen.arya@nhs.net

• Sponsor organisation

  Bayer Plc

• REC name

  London - Stanmore Research Ethics Committee

• REC reference

  13/LO/0131

• Date of REC Opinion

  14 Feb 2013

• REC opinion

  Favourable Opinion